Skip to main content
Explore URMC
menu

Scott A. Gerber, Ph.D.

Contact Information

Phone Numbers

Administrative: (585) 275-1488

Office: (585) 276-7380

Research Labs

Faculty Appointments

Biography

Research

Dr. Gerber is a tumor immunologist whose laboratory focuses on harnessing the immune system to recognize and kill cancerous cells. His lab uses an immunotherapeutic approach to enhance the efficacy of chemo/radiotherapies to control or even cure both primary and metastatic malignancies.

Credentials

Education

1997
BS | SUNY Coll at Fredonia
Biology

2001
MS | University of Rochester School of Medicine & Dentistry
Immunology

2005
PhD | University of Rochester School of Medicine & Dentistry
Microbiology & Immunology

Post-doctoral Training & Residency

2005 - 2008
Yale University, New Haven, CT (Mentor: Jordan Pober)

Awards

2019
National Cancer Institute R01 CA230277

2019
URMC Outstanding Graduate Student Teacher Award

2018 - 2019
University Research Award

2018
Clinical and Translational Science Institute Pilot Study Award

2017
Wilmot Cancer Institute Collaborative Award

2016
Washington University SPORE in Pancreatic Cancer Developmental Research Award

2016
UR/UB Genomics Collaborative Pilot Award

2012 - 2013
American Association of Immunologist (AAI) Early Career Faculty Travel Grant

2008
Anna Fuller Fund Fellowship in Molecular Oncology
Sponsor: Yale University
Location: New Haven, CT

2006
Vincent du Vigneaud Award for outstanding doctoral thesis
Sponsor: University of Rochester Medical Center
Location: Rochester, NY

VIEW ALL expand_more

Publications

Journal Articles

7/18/2022
Probst V, Spieker AJ, Stopczynski T, Stewart LS, Haddadin Z, Selvarangan R, Harrison CJ, Schuster JE, Staat MA, McNeal M, Weinberg GA, Szilagyi PG, Boom JA, Sahni LC, Piedra PA, Englund JA, Klein EJ, Michaels MG, Williams JV, Campbell AP, Patel M, Gerber SI, Halasa NB. "Clinical Presentation and Severity of Adenovirus Detection Alone vs Adenovirus Co-detection With Other Respiratory Viruses in US Children With Acute Respiratory Illness from 2016 to 2018." Journal of the Pediatric Infectious Diseases Society.. 2022 Jul 18; Epub 2022 Jul 18.

7/15/2022
Battaglia NG, Murphy JD, Uccello TP, Hughson A, Gavras NW, Caldon JJ, Gerber SA, Lord EM. "Combination of NKG2A and PD-1 Blockade Improves Radiotherapy Response in Radioresistant Tumors." The Journal of immunology : official journal of the American Association of Immunologists.. 2022 Jul 15; Epub 2022 Jul 15.

7/2022
Ye J, Mills BN, Qin SS, Garrett-Larsen J, Murphy JD, Uccello TP, Han BJ, Vrooman TG, Johnston CJ, Lord EM, Belt BA, Linehan DC, Gerber SA. "Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer." Journal for immunotherapy of cancer.. 2022 Jul; 10(7)

VIEW ALL PUBLICATIONS